Nebojša Skrepnik
-
- Tendon Structure and Treatment 3
- Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms 12
- Urology top 5%
- Surgery top 10%
- Knee injuries and reconstruction techniques 5
- Developmental Biology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Cancer Research and Treatments 3
-
- Cancer, Hypoxia, and Metabolism 3
-
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 3
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- John J. SpitzerScott G. EdwardsMatthew L. RamseyDavid C. KarliGrant L. JonesAllan MishraSteven SampsonArthur C. Rettig
- Partner nations
- United StatesFranceCanada
In The Last Decade
Nebojša Skrepnik
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Orthopedics and Sports Medicine 255
- Rheumatology 372
- Urology 107
- Surgery 503
- Developmental Biology 23
Countries citing papers authored by Nebojša Skrepnik
This map shows the geographic impact of Nebojša Skrepnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nebojša Skrepnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nebojša Skrepnik more than expected).
Fields of papers citing papers by Nebojša Skrepnik
This network shows the impact of papers produced by Nebojša Skrepnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nebojša Skrepnik. The network helps show where Nebojša Skrepnik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nebojša Skrepnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 11 | |
| 3 | 2021 | 73 | |
| 4 | 2020 | 26 | |
| 5 | 2019 | 9 | |
| 6 | 2018 | 25 | |
| 7 | 2017 | 68 | |
| 8 | 2017 | 108 | |
| 9 | 2016 | 10 | |
| 10 | 2012 | 90 | |
| 11 | 2011 | 7 | |
| 12 | 2009 | 28 | |
| 13 | 1999 | 11 | |
| 14 | 1998 | 3 | |
| 15 | 1997 | 10 | |
| 16 | Effects of anti-erbB-2 (HER-2/neu) recombinant oncotoxin AR209 on human non-small cell lung carcinoma grown orthotopically in athymic nude mice. | 1996 | 11 |
| 17 | 1996 | 36 | |
| 18 | 1996 | 10 | |
| 19 | 1992 | 12 | |
| 20 | 1990 | 3 |
About Nebojša Skrepnik
Nebojša Skrepnik is a scholar working on Rheumatology, Endocrinology, Diabetes and Metabolism and Biophysics, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (12 papers), Knee injuries and reconstruction techniques (5 papers), Tendon Structure and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (255 citations), Rheumatology (372 citations) and Urology (107 citations). Nebojša Skrepnik has collaborated with scholars based in United States, France and Canada. Frequent co-authors include John J. Spitzer, Scott G. Edwards, Matthew L. Ramsey, David C. Karli, Grant L. Jones, Allan Mishra, Steven Sampson, Arthur C. Rettig, Gregory J. Bagby and Ion V. Deaciuc. Their work appears in journals such as Hepatology, Cancer and The American Journal of Sports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.